Ubrogepant (Ubrelvy) is the first oral calcitonin gene-related peptide receptor antagonist approved by the FDA for the acute treatment of migraine.
Fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo and AstraZeneca) is a new treatment option for patients with HER2-positive breast cancer who have progressed after 2 or more prior regimens.
A set of performance measures for older adults with type 2 diabetes at greater risk for hypoglycemia published by the Endocrine Society and Avalere Health.
A study examined influenza vaccination requirements for children who attend child care centers.
Officials with the FDA have approved a new indication and label expansion for icosapent ethyl (Vascepa, Amarin).
One in 5 older adults said that they’ve taken leftover antibiotics from a previous prescription without checking in with a health care professional.
Louisiana, along with other southern and southwestern US states, topped the Walgreens Flu Index report for highest incidences of flu for November.
A new study shows increases in the misuse of non-opioid medications among US adults coinciding with decreases in opioid prescribing.
Pharmacist-led initiatives, such as medication therapy management, for chronic diseases can significantly improve patient outcomes.
The FDA issued warning letters to several companies marketing their CBD products in ways that violate the Federal Food, Drug, and Cosmetic Act.